Gastroparesis Trial, Recruiting NCT06340217 Sponsor: The Second Hospital of Nanjing Medical University Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT06340217
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with diabetes for more than 1 year
  • You have had stomach symptoms like bloating or feeling full very quickly after eating, lasting for at least 3 months, and these symptoms score at a certain level of severity (confirm with trial site)
  • You have had a test in the past 3 months (such as a scan or ultrasound) that shows your stomach empties food more slowly than normal
  • You have had a scan or camera test in the past 3 months that ruled out any blockages in your upper digestive system
  • You are male, or a female who is not pregnant or breastfeeding, and you are over 18 years old
  • You are willing and able to give your agreement to take part, understand what the study involves, and follow the study requirements (a legal representative may do this on your behalf if needed)

Who may not be able to join:

  • You have a stomach or digestive condition other than diabetic gastroparesis (slow stomach emptying due to diabetes) that would need different treatment
  • You have had stomach surgery (such as gastric bypass, stomach removal, stomach banding, or related procedures) in the past year
  • Your slow stomach emptying appears to be caused by something other than diabetes, such as another illness or nerve condition
  • You are currently taking medications that affect how your digestive system moves, such as GLP-1 medications (a type of diabetes or weight-loss drug)
  • You have a condition that means a tube cannot safely be placed in your intestine (confirm with trial site)
  • You have taken any medication in the last 48 hours that affects the bacteria in your gut
  • You have a serious diabetes complication that needs immediate treatment, such as diabetic ketoacidosis
  • You have poor lung function that the trial doctor believes could be affected by the study treatment, for example if you have a lung condition that is currently getting worse
  • You have certain heart problems, including: a heart function rating of Class III or higher; a heart attack or unstable chest pain within the last 6 months; an abnormal heart rhythm reading on an ECG of a specific type; or a heart electrical conduction problem that requires medication (confirm with trial site)
  • You have moderate or severe liver disease (confirm with trial site)
  • You have significant kidney disease where your kidneys are working at a reduced level (confirm with trial site)
  • You have an active infectious disease such as active hepatitis requiring long-term medication, HIV, or active tuberculosis
  • You drink heavily — defined as more than 14 units of alcohol per week (roughly more than 14 standard drinks), or have a history of drug or substance misuse
  • You have another serious illness, such as cancer
  • The trial doctor decides for any other reason that it would not be appropriate for you to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Faming Zhang, The Second Hospital of Nanjing Medical University

Phone: 086-025-58509883

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Second Hospital of Nanjing Medical University
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 January 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The proportion of DGP with symptom relief after the procedure.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov